PharmaVault
گنجینه اطلاعات داروسازی
The Pharmaceutical Information Vault
Excipient monograph · مونوگراف ماده جانبی
pharmavault.ir
Bentonite
بنتونیت
1Nonproprietary names
- BPBentonite
- JPBentonite
- Ph. Eur.Bentonite
- USP–NFBentonite
2Synonyms and trade names
Bentonitum; mineral soap; montmorillonite clay; soap clay; taylorite; wilkinite
3Chemical name and CAS Registry Number
Bentonite (native colloidal hydrated aluminium silicate, mainly montmorillonite) · [1302-78-9]
4Empirical formula and molecular weight
Al2O3·4SiO2·H2O (idealised)
5Functional category
Gelling agent, viscosity modifier, Adsorbent
Typical concentrations: — · Dosage forms: Liquid, Semi-solid
6Applications in pharmaceutical formulation
Used as a suspending agent and viscosity builder in oral and topical suspensions, lotions and creams, as an emulsion stabiliser, and as an adsorbent and clarifying agent. Typical concentrations: suspending agent 0.5–5%; emulsion stabiliser about 1%; adsorbent and clarifying agent variable.
7Description
A very fine, odourless, pale buff or cream to greyish-white powder, free from grit, with a slightly earthy taste. It consists of particles about 50–150 µm along with numerous particles of colloidal size, and its plate-like montmorillonite layers carry exchangeable cations, usually sodium or calcium.
8Typical properties
- pH
- 9.5–10.5 (2% w/v aqueous suspension)
- Loss on drying
- about 5–8% w/w
- Swelling
- swells markedly in water, up to about 12 times its dry volume, forming thixotropic dispersions and, at higher concentrations, gels
- Solubility
- practically insoluble in water, ethanol and other organic solvents
9Stability and storage conditions
Hygroscopic. Store in an airtight container in a cool, dry place. Aqueous suspensions are fairly stable and can be sterilised by autoclaving; they support microbial growth, so a preservative is needed.
10Incompatibilities
Aqueous dispersions are flocculated and lose viscosity in the presence of electrolytes and acids, and are most stable above about pH 6. The negatively charged clay adsorbs cationic drugs and preservatives (for example quaternary ammonium compounds), which can reduce their activity or availability.
11Method of manufacture
Mined from natural deposits formed by weathering of volcanic ash, then dried, milled and sieved; it may be purified or treated to adjust the exchangeable cation content.
12Safety
Not absorbed after oral administration and regarded as non-toxic and non-irritant in oral and topical use. It must not be given parenterally. Prolonged inhalation of the dust should be avoided because of possible crystalline silica content.
13Handling precautions
Observe normal precautions for the quantity handled. Use eye protection and a dust mask, and avoid creating dust.
14Regulatory status
GRAS listed. Included in the FDA Inactive Ingredient Database (oral and topical preparations) and in non-parenteral medicines licensed in Europe.
15Related substances
Attapulgite; kaolin; magnesium aluminium silicate; purified bentonite; hectorite.
16Comments
Bentonite hydrates best when sprinkled onto the surface of water and left to stand, or when dispersed with high-shear mixing; adding water to the powder tends to form lumps. Pre-wetting with glycerol also helps dispersion.